ATTENTION: HealthWell Foundation headquarters and hotline will be closed on Tuesday, November 11, 2025, in observance of the holiday and will re-open on Wednesday, November 12, 2025, at 9:00 a.m. We encourage you to continue to use our Patient, Pharmacy and Provider Portals during this time. If you have a question that cannot be answered by visiting the portal, please send an email to [email protected]. We appreciate your patience and look forward to serving you. The HealthWell Team
Multiple Myeloma - Medicare Access (Medicare patients only)
Status
OpenAssistance Type
Prescription Drug Copayor
Insurance premium (Medicare Part B only)
Maximum Award Level
Pharmacy Card Fund
YesMinimum Copay Reimbursement Amount
We encourage you to please use your HealthWell pharmacy card for any applicable charges as possible.
Minimum Premium Reimbursement Amount
Household Income Limit
500% of the Federal Poverty Level(adjusted for household size and high cost of living areas)
Treatments Covered
- Abecma
- Adriamycin
- Alkeran
- Alkindi Sprinkle
- Aphexda
- Arsenic Trioxide
- Aspirin
- Belrapzo
- Bendamustine Hydrochloride
- Bendeka
- Betamethasone
- Betamethasone Acetate-betamethasone Sodium Phosphate
- Betamethasone Sodium Phosphate
- Bicnu
- Bilprevda
- Bomyntra
- Bortezomib
- Boruzu
- Busulfan
- Busulfex
- Calcitonin-salmon
- Carfilzomib
- Carmustine
- Carvykti
- Celestone Soluspan
- Ciltacabtagene Autoleucel
- Cisplatin
- Conexxence
- Cortef
- Cortisone Acetate
- Cyclophosphamide
- Daratumumab
- Daratumumab And Hyaluronidase-fihj
- Darzalex
- Darzalex Faspro
- Decadron
- Denosumab
- Denosumab-bbdz
- Denosumab-bnht
- Depo-medrol
- Dex24
- Dexabliss 11-day Dose Pack
- Dexamethasone
- Dexamethasone Sodium Phosphate
- Doxil
- Doxorubicin Hcl Liposome
- Doxorubicin Hydrochloride
- Durlaza
- Dxevo
- Ellence
- Elotuzumab
- Elranatamab-bcmm
- Elrexfio
- Empliciti
- Enoxaparin Sodium
- Epirubicin Hydrochloride
- Etopophos
- Etoposide
- Etoposide Phosphate
- Evomela
- Farydak*
- Filgrastim
- Filgrastim-aafi
- Filgrastim-ayow
- Filgrastim-sndz
- Filgrastim-txid
- Fluor-a-day
- Fluoride
- Fluoritab
- Flura-drops
- Gliadel
- Hemady
- Hepzato
- Hidex
- Hydrocortisone
- Hydrocortisone Sodium Succinate
- Idecabtagene Vicleucel
- Ifex
- Ifosfamide
- Isatuximab-irfc
- Ivra
- Ixazomib
- Kemoplat
- Kyprolis
- Lenalidomide
- Lovenox
- Ludent Fluoride
- Lynozyfic
- Matulane*
- Medrol
- Mekinist
- Melphalan
- Methylprednisolone
- Methylprednisolone Acetate
- Methylprednisolone Sodium Succinate
- Miacalcin
- Millipred
- Motixafortide
- Mozobil
- Myleran
- Neupogen
- Ninlaro
- Nivestym
- Nypozi
- Orapred Odt
- Paclitaxel
- Pamidronate Disodium
- Panobinostat*
- Pediapred
- Plerixafor
- Pomalidomide
- Pomalyst
- Prednisolone
- Prednisolone Sodium Phosphate
- Prednisone
- Prevident Dental Rinse
- Procarbaine Hcl*
- Prolia
- Rayos
- Reclast
- Releuko
- Revlimid
- Rivaroxaban
- Sarclisa
- Selinexor
- Sodium Fluoride
- Solu-cortef
- Solu-medrol
- Talquetamab-tgvs
- Talvey
- Taperdex
- Teclistamab-cqyv
- Tecvayli
- Teniposide*
- Thalidomide
- Thalomid
- Trametinib Dimethyl Sulfoxide
- Treanda
- Trisenox
- Velcade
- Venclexta
- Venetoclax
- Veripred 20
- Vincristine Sulfate
- Vivimusta
- Vorinostat
- Wyost
- Xarelto
- Xgeva
- Xpovio
- Z-cort 7-day
- Zarxio
- Zoledronic Acid
- Zolinza
- Zometa
Fund Definition
Assistance with the prescription drugs and biologics used in the treatment of multiple myeloma.
Grant Utilization
As a result of the impact of the Inflation Reduction Act on Medicare Part D maximum out of pocket, average grant utilization calculation for Medicare Access Funds are based on forecasted utilization. The forecasted average grant utilization for this disease fund is: $4,000Do I Qualify?
HealthWell bases eligibility on an individual’s medical, financial and insurance situation. To qualify for HealthWell’s assistance, applicants must meet the following eligibility requirements:
-
Please make sure that HealthWell currently has a fund for your diagnosis/indication and that your medication is covered under that fund by visiting our Disease Funds listing. If we do not have a fund that currently covers your diagnosis, please check back as we frequently open and reopen programs as funding becomes available. The Foundation is able to help patients receiving treatment for indications for which we currently have an open fund. We can only assist with medications that have been prescribed to treat the disease/covered diagnosis. You will be asked to provide the Foundation with the patient’s diagnosis, which must be verified by a physician, nurse practitioner, or physician assistant’s signature. The patient must receive treatment in the United States.
-
This is a Medicare Access Fund. In order to qualify for premium assistance through this fund, you must have Medicare Part B. The Foundation will refer patients without Medicare to other programs, such as manufacturer patient assistance programs.
-
HealthWell assists individuals with incomes up to 300-500% of the Federal Poverty Level. The Foundation also considers the number in a household and cost of living in a particular city or state. If you believe you qualify for assistance, you may begin the application process here.
-
If you are receiving treatment in the U.S. and have met the eligibility criteria as listed, you are ready to apply! Please note that you will be asked to provide a Social Security Number in order to create a grant. This information is gathered to eliminate duplicate applications and is kept secure and confidential.
About Multiple Myeloma
Multiple myeloma is type of cancer that begins in plasma cells (white blood cells that produce antibodies). Multiple myeloma causes cancer cells to accumulate in the bone marrow, where they crowd out healthy blood cells. Source: National Cancer Institute, Mayo Clinic
Additional Educational Resources
- American Cancer Society
- American Society of Clinical Oncology
- CancerCare
- Cancer Support Community
- International Myeloma Foundation
- Multiple Myeloma Research Foundation
- National Coalition for Cancer Survivorship
- National Infusion Center Association
You may also visit our Resource List to view other copayment organizations that may provide assistance.